Subacute cutaneous lupus erythematosus induced by capecitabine.
Floristan
U
U
Feltes
R A
RA
Sendagorta
E
E
Feito-Rodriguez
M
M
Ramírez-Marín
P
P
Vidaurrázaga
C
C
Casado-Jiménez
M
M
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000069287:Capecitabine; D015179:Colorectal Neoplasms / Q000188:drug therapy; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D003875:Drug Eruptions / Q000209:etiology*; D005148:Facial Dermatoses / Q000139:chemically induced; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced*
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil